High-grade astrocytoma, which includes glioblastoma, is a fast-growing, aggressive brain cancer that often returns after the tumor is removed, making it difficult to treat. Patients with recurrent ...

The third patient showed stable disease with a 30% reduction in tumor size. ・Alpha Tau reported no unexpected serious adverse events through May 3, 2026. ・As of the cutoff date, none of the patients ...

Stereotactic radiosurgery (SRS) for cancer patients who receive the treatment for brain metastases decreases the likelihood of local recurrence but shows no positive difference in terms of overall ...

What Is Modeyso Used For? Modeyso is used to treat a type of recurrent brain cancer known as a diffuse midline glioma with a specific genetic mutation known as histone 3 (H3) K27M. Diffuse midline ...

A research team led by Professor Jason Kyungha Sa from the Department of Biomedical Informatics at Korea University College of Medicine has identified a novel therapeutic target for recurrent ...

Alpha Tau Medical (NASDAQ:DRTS) presented early clinical results from the first three patients treated in its REGAIN study of ...

Interim results from the first three brain cancer patients treated; two of whom demonstrated complete response, with total disappearance of all ...

A woman with a family history of cancer paid out-of-pocket for a full-body MRI scan (Prenuvo) as a proactive health measure. The scan detected a walnut-sized brain tumor in her temporal lobe, a rare ...

Scientists are creating a glioblastoma 'tumor on a chip'—a tiny living system capable of mimicking the key features of the ...